The small to mid market cap biotech/healthcare section of the market has had a banner year in 2019 with numerous stocks enjoying the benefit of success in the clinic as well as regulatory and commercialisation success.
We have selected three stocks which we believe will deliver a solid performance in FY20. Our top picks for the Industrials sector are Imdex (IMD), Carbon Revolution (CBR) and Frontier Digital Ventures (FDV).
Due to the cyclical nature of investments in the Travel & Tourism sector, we've chosen stocks with a diversified business model across multiple travel businesses with exposure to global growth opportunities.
On the back of challenging macro stimulus and cautious discretionary spending, our top picks focus on retailers that offer growth through global expansion opportunities or structural tailwinds (such as the shift to online).
We continue to be positive on the technology sector in Australia. In an environment of low interest rates and low growth, we believe there are a number of good quality stocks in the sector with reasonable to strong growth outlooks.